Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Nurs Res. 2022 Dec 9;72(2):103–113. doi: 10.1097/NNR.0000000000000636

Table 4.

Multivariable Models for Symptom Outcomes

Outcome Number of symptomsa
R2 = .30
Symptom severity indexb
R2 = .38
Depressive symptomsc
R2 = .47
Anxietyd
R2 = .32
Predictor Coefficient (SE) p Coefficient (SE) p Coefficient (SE) p Coefficient (SE) p
Age −0.06 (0.02) <. 01 −0.32 (0.10) <.01 −0.11 (0.04) .01 −0.08 (0.04) .04
Number of comorbid conditions 0.56 (0.07) < .01 3.68 (0.45) <.01 0.83 (0.20) <.01 0.23 (0.20) .25
Social isolation 0.11 (0.02) < .01 0.79 (0.12) <.01 0.72 (0.05) <.01 0.55 (0.05) <.01
Race/Ethnicity
Hispanic 0.17 (0.43) .69 5.41 (2.70) .04 1.53 (1.17) .19 0.23 (1.20) .85
Non-Hispanic other races 0.77 (0.60) .20 9.46 (3.79) <.01 0.00 (1.63) .99 −0.73 (1.66) .67
Non-Hispanic White Ref. Ref. Ref. Ref.
Income meets needs
Meets −0.31 (0.64) .63 −11.52 (4.04) < .01 −2.91 (1.76) .10 0.17 (1.80) .92
Barely −0.09 (0.64) .88 −6.25 (3.77) < .01 −1.38 (1.64) .40 1.43 (1.69) .40
Not all Ref. - Ref. - Ref. - Ref. -
Level of education
More than high school −0.59 (0.40) .14 −2.23 (2.48) .37 −0.85 (1.08) .43 −0.25 (1.10) .82
High school or less Ref. Ref. Ref. Ref.
Marital status
Not married −0.25 (0.36) .49 1.47 (2.28) .52 0.87 (0.99) .38 −0.70 (1.01) .49
Married Ref. Ref. Ref. Ref.
Population of residence
<100,000 people −0.83 (0.39) .04 −3.79 (2.47) .13 −3.10 (1.07) < .01 −2.70 (1.11) .02
100,000 or more Ref. Ref. Ref. Ref.
Cancer and treatment
Female breast chemotherapy/other targeted therapy 5.81 (3.05) .06 0.83 (1.32) .53 0.11 (1.36) .93
Female colorectal/GI 0.27 (0.70) .69 6.20 (4.38) .16 −0.46 (1.91) .81 −0.85 (1.96) .66
Male colorectal/GI 2.72 (0.80) < .01 13.96 (5.06) < .01 0.72 (2.20) .74 −0.89 (2.25) .69
Female other 0.45 (0.54) .40 9.83 (3.36) < .01 1.40 (1.46) .34 −0.81 (1.49) .58
Male other 1.22 (0.58) .03 10.36 (3.61) < .01 0.61 (1.56) .70 −2.02 (1.60) .21
Female breast hormonal therapy Ref. Ref. - Ref. Ref.
Metastatic cancer
Yes 0.45 (0.34) .19 2.14 (2.15) .32 1.34 (0.94) .15 0.96 (0.49) .63
No Ref. Ref. Ref. Ref.

Note.

a

Number of symptoms-potential range 0–17, includes depression and anxiety, higher score = more symptoms;

b

Summed symptom severity-potential range 0–150, without depression and anxiety, higher score = greater severity;

c

Center for Epidemiological-Depression scale (CES-D)-potential range 0–60, higher score = worse depression;

d

Anxiety Patient Reported Outcomes Measurement Information System (PROMIS)-T scores range 43.2–83.1, higher score = more anxiety